The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides adult flu vaccines for the 2023-2024 period. Glaxosmithkline, LLC was awarded a multiple award contract with a potential value of $13.9 million to deliver flu vaccines through February 2028 under associated task orders or price lists.
The solicitation aimed to procure adult flu vaccines to support the Centers for Disease Control and Prevention's flu prevention programs. As the leading public health agency, the CDC works to protect public health and safety through the control and prevention of infectious diseases like influenza. This contract will aid the CDC's efforts by providing cost-effective access to flu vaccines during the upcoming seasons. Glaxosmithkline will deliver the vaccines to locations specified in task orders to support distribution of flu vaccines nationwide through the period of performance.
Generated 1/5/24, 12:43 AM